Psilocybin’s ‘Efficacy And Safety’ For Bipolar II Depression Demonstrated By American Medical Association Study

Marijuana Moment
By Ben AdlinDec 6, 2023, 11:03 am311 ptsTop
Results of a new clinical trial published by the American Medical Association “suggest efficacy and safety” of psilocybin-assisted psychotherapy for treatment of bipolar II disorder, a mental health condition often associated with debilitating and difficult-to-treat depressive episodes. “The 15…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Montana Gov. Vetoes Bill on Tribal Cannabis Agreements 69

Texas Cannabis Battle 59

Thai cannabis advocates plan rally over imminent re-criminalization 56

Marijuana Mandani: NYC's Next Mayor Is Very Pro-Cannabis 48

Marijuana Mamdani: NYC's Next Mayor Is Very Pro-Cannabis 48

FDA Plan To Include Hemp-Derived Cannabinoids In Federal Adverse Health Event Reporting System Goes To White House For Approval 45

Cannabis Branding and Trademark Protection 42

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.